AALI PHARMA LTD
Opportunity 70/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (69/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 105 (micro)Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · FRS 105 (micro)| Metric | 2025-01-31 |
|---|---|
| Total assets | £1.5k |
| Current assets | £12.1k |
| Net assets | £982 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
Corporate timeline (4 events)Click to expand
- 2025-03-05📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-01-17🏢Company incorporatedAs AALI PHARMA LTD
- 2024-01-17➕ALI, Aysha Khatun appointeddirector
- 2024-01-17📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 2.3 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Miss Aysha Khatun Ali Individual · British · DOB 12/1996 · age 30 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 17/01/2024 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · BD postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 09 CARE LIMITED→ 14266410 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| 09692011 LTD→ 09692011 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| 1ST STEPS WITH US LTD→ 11243660 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| 2020 VISION LIMITED→ 16267111 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| 247 ON CALL LIMITED→ 13138239 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| 7N OPTICAL LIMITED→ 14085984 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| A AND E LOCUM SERVICES LIMITED→ 11145422 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| A.A CARE LTD→ 13385369 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AA PHYSIO LIMITED→ 15720070 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AAMAN PHARMA LTD→ 16065221 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AAMANAH CARE GROUP LTD→ 16643097 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AAMANAH CARE SERVICES LTD→ 16946633 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.